Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Renovaro Biosciences ( (RENB) ) has provided an update.
Renovaro Inc. received a notice from Nasdaq on July 7, 2025, for non-compliance with the requirement to hold an annual meeting of shareholders within twelve months of the fiscal year-end. Nasdaq accepted the company’s plan to regain compliance, granting an extension until October 31, 2025, to hold the meeting.
More about Renovaro Biosciences
Average Trading Volume: 3,669,929
Technical Sentiment Signal: Sell
Current Market Cap: $57.13M
See more insights into RENB stock on TipRanks’ Stock Analysis page.